CERS2 and Insulin resistance: A recent study (35) in cardiomyocytes showed that overexpression of CerS2 elevated levels of very-long-chain ceramides and caused insulin resistance, oxidative stress, mitochondrial dysfunction, and mitophagy, suggesting a similar mechanism in cardiomyocytes from patients with FRDA.